The Motley Fool

Key Data Points

Primary metrics and data points about Celgene.
Current Price: $116.67
Prev Close: $112.19
Open: $112.81
Bid: $116.72
Ask: $116.77
Day's Range: $110.88 - $118.50
52wk Range: $83.16 - $140.72
Volume: 7,287,959
Avg Vol 6,282,951
Market Cap: $92B
P/E (ttm): 42.50
EPS (ttm): $2.64
Div & Yield: $0.00 (0.0%)

News and Headlines

Latest news about Celgene from

Business Summary

Industry, sector and description for Celgene.

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

CELG vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Celgene.
CAPS Rating 5 out of 5
2042 Outperform
74 Underperform
CAPS All Stars
462 Outperform
13 Underperform

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Robert J. Hugin, CEO

97% Approve

Based on 57 Ratings

More Details for CelgeneJobs

Powered by

More Details about Celgene

Primary metrics and data points about Celgene.